Xiaodong Wang

机构：Peking University, Peking University Cancer Hospital · ORCID：0000-0003-4727-9742

发表论文 54 篇 · 总被引 810 次 · h-index 17

代表论文

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial (2022 · Radiology · 被引 160)
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations (2023 · Hepatology International · 被引 57)
Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels (2020 · BMJ Open Diabetes Research & Care · 被引 39)
Bioimpedance spectroscopy can precisely discriminate human breast carcinoma from benign tumors (2017 · Medicine · 被引 32)
Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD ‐related liver fibrosis (2023 · Liver International · 被引 31)
Perioperative advantages of modified laparoscopic vs open splenectomy and azygoportal disconnection. (2014 · PubMed · 被引 29)